VISTAGEN THERAPEUTICS, INC. Accounts Payable
VISTAGEN THERAPEUTICS, INC. (VTGN) had Accounts Payable of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $1.00M.
- 2026-03-31: Accounts Payable, Current $1.53M.
- 2025-12-31: Accounts Payable, Current $1.28M.
- 2025-09-30: Accounts Payable, Current $1.83M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.53M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.28M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $1.83M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $486.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $653.00K 10-K · filed 2026-06-15 | |
| 2024-12-31 | $1.04M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $715.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.21M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.55M 10-K · filed 2025-06-17 | |
| 2023-12-31 | $1.74M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $1.30M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.62M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $2.47M 10-K · filed 2024-06-11 | $2.47M 10-K · filed 2023-06-28 |
| 2022-12-31 | $1.60M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $2.96M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.47M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.76M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $1.95M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $2.66M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $2.32M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $838.30K 10-K · filed 2022-06-23 | |
| 2020-12-31 | $776.40K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $1.18M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.31M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $1.84M 10-K · filed 2021-06-29 | |
| 2019-12-31 | $1.61M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $1.45M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $933.90K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.05M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $1.09M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $590.10K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $629.50K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.20M 10-K · filed 2019-06-25 | |
| 2017-12-31 | $509.30K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $1.15M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $632.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $867.30K 10-K · filed 2018-06-26 | |
| 2016-12-31 | $874.40K 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $930.20K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $930.10K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $936.00K 10-K · filed 2017-06-29 | |
| 2015-12-31 | $1.10M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.11M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.55M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $2.25M 10-K · filed 2016-06-24 | |
| 2014-12-31 | $2.42M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $2.25M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $1.90M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $2.44M 10-K · filed 2015-06-29 | |
| 2013-12-31 | $2.26M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $1.98M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.76M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.44M 10-Q · filed 2014-11-19 | $1.35M 10-K · filed 2013-07-18 |
| 2012-12-31 | $1.25M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $1.47M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.56M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.35M 10-Q · filed 2013-11-14 | $1.75M 10-K · filed 2012-07-02 |
| 2011-12-31 | $1.04M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $1.24M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $943.24K 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $1.77M 10-K · filed 2012-07-02 | $1.77M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |